Zusammenfassung
Antiemetika und Antivertiginosa werden zur Behandlung von Erbrechen und Schwindel eingesetzt. Der weitaus größte Teil der Verordnungen entfällt auf Betahistin für Patienten mit Morbus Menière. Schwerpunkt der H1-Antihistaminika sind Prophylaxe und symptomatische Therapie von Übelkeit und Erbrechen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Baloh RW (2003): Clinical practice. Vestibulär neuritis. N Engl J Med 348: 1027–1032
Billio A, Morello E, Clarke MJ (2010): Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006272 Brandt T, Dichgans J, Diener HC (Hrsg) (1998): Therapie und Verlauf neurologischer Erkrankungen. 3. Aufl, Verlag Kohlhammer, Stuttgart Berlin Köln S. 127–156
Hamann K-F, Arnold W (1999): Meniere's disease. In: Büttner U (ed): Vestibular dysfunction and its therapy. Adv ORL 55: 137–168
Ihler F, Bertlich M, Sharaf K, Strieth S, Strupp M, Canis M (2012): Betahistine exerts a dose-de- pendent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS One 7: e3908–6
James A, Burton MJ (2009): Betahistine for Meniere's disease or syndrome. Cochrane Database of Systematic Reviews 2001, Issue 1. Publication status and date: Edited (no change to conclusions), published in Issue 1,2009. Art. No.: CD001873. DOI: 10.1002/14651858. CD001873
Kranke P, Morin AM, Roewer N, Eberhart LH (2002): Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand 46: 238–244
Lacour M, van de Heyning PH, Novotny M, Tighilet B (2007): Betahistine in the treatment of Meniere's disease. Neuropsychiatr Dis Treat 3: 441–453
Molino A, Guglielmo L, Azzolini ME, Biondani P, Capelli MC, Grandinetti A, Griso C, Martinelli G, Martini N, Zanotti R, et al. (1991): The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study. Oncology 48: 111–115
Spinks AB, Wasiak J, Villanueva EV, Bernath V (2007): Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002851 Strupp M, Brandt T (2013): Peripheral vestibular disorders. Curr Opin Neurol 26: 81–89
Westhofen M (2009): M. Meniere. Evidenzen und Kontroversen. HNO 57: 446–454
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hamann, KF. (2015). Antiemetika und Antivertiginosa. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2015. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47186-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-47186-9_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-47185-2
Online ISBN: 978-3-662-47186-9
eBook Packages: Medicine (German Language)